Acción anti-proliferativa de silibinina sobre el cáncer adenomatoso de colon humano las células HT-29

11Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Silibinin a flavonoid from milk thistle (Silybum marianum) exhibit a variety of pharmacological actions, including anti-proliferative and apoptotic activities against various types of cancers in intact animals and cancer cell lines. In the present study, the effect of silibinin on human colon cancer HT-29 cells was studied. Method: Incubations of cells with different silibinin concentrations (0.783-1,600 ug/ml) for 24, 48 or 72 h showed a progressive decline in cell viability. Results: Loss of cell viability was time dependent and optimum inhibition of cell growth (78%) was observed at 72 h. Under inverted microscope, the dead cells were seen as cell aggregates. IC50 (silibinin concentration killing 50% cells) values were 180, 110 and 40ug/ml at 24, 48 and 72 h respectively. Conclusion: These findings re-enforce the anticancer potential of silibinin, as reported earlier for various other cancer cell lines (Ramasamy and Agarwal (2008), Cancer Letters, 269: 352-62).

Cite

CITATION STYLE

APA

Akhtar, R., Ali, M., Mahmood, S., & Nath Sanyal, S. (2014). Acción anti-proliferativa de silibinina sobre el cáncer adenomatoso de colon humano las células HT-29. Nutricion Hospitalaria, 29(2), 388–392. https://doi.org/10.3305/nh.2014.29.2.7080

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free